By writer to www.uab.edu
Media contact: Adam Pope
The grant will fund her undertaking “Selling Will increase in Residing Organ donation through Tele-navigation.”
In 2017, Locke was awarded her first R01 grant from the NIDDK for her analysis “CKD Danger Prediction amongst Overweight Residing Kidney Donors.” The roughly $3.Three million, five-year award will conclude in 2022.
Final yr, Locke received her second R01 grant, funded by the NIH, NIDDK, and United States Division of Well being and Human Companies. The grant helps her undertaking “Genetic, Environmental & Histologic Foundation for Kidney Illness Danger amongst Individuals Residing with HIV” throughout 5 years.
In all, her three R01 grants have totaled greater than $10.5 million.
Locke said, “Geographic disparities in chance of residing donor kidney transplantation exist with the southeastern United States having the bottom charges. Present applications to extend LDKT have did not slim geographic gaps as they had been developed and carried out in resource-intense city settings limiting generalizability in rural areas. Furthermore, no present program has addressed donor issues impeding sustained LDKT will increase.”
Her latest undertaking will make the most of affected person navigators, with experience in relationship constructing, to beat donor-related issues relating to analysis processes and academic programming supply, and broaden a navigator-based coaching platform through telehealth. This might be a novel methodology for overcoming geographic disparities in entry to LDKT.
Finally, this analysis may assist mitigate disparities in LDKT. Locke will have interaction her well being companies analysis group, Transplant Epidemiology and Analytics in Medicine, to finish the three R01 grants.
Herbert Chen, M.D., Fay Fletcher Kerner Endowed Chair, is pleased with Locke and the affect of her analysis on nationwide organ donation coverage and process.
“Dr. Locke has tirelessly devoted herself to the reason for lowering disparities in entry to transplantation, and your entire division is so pleased with her laborious work,” Chen mentioned. “Dr. Locke and the TEAM lab are spectacular advocates for fairness in medication.”
— to www.uab.edu